GuruFocus Updates (Free subscription) | 08/15/2008
While a lot of value investors got hurt with the recent downturn, Bruce Berkowitz did well by owning energy stocks and not owning financials. Now the "Ignore the Crowd" guru is reducing energy holdings and invest heavily into healthcare stocks. These are his buys and sells during the second quarter.
GuruFocus Updates (Free subscription) | 08/13/2008
buys Covidien Ltd., Brookfield Asset Management Inc. Ltd., HUNTER DOUGLAS NV, Staples Inc., Exxon Mobil Corp., UDR Inc., Pfizer Inc, Chevron Corp., ScheringPlough Corp., Yahoo! Inc., Merck & Co. Inc., PepsiCo Inc., WellPoint Inc., IngersollRand Company Ltd., Eli Lilly and Company, Oracle Corp., Verizon Communications Inc., Zimmer Holdings Inc.,...
Market Watch (Free subscription) | 07/22/2008
NEW YORK (MarketWatch) -- Forest Laboratories Inc. said Tuesday that it earned $242.9 million, or 79 cents a share, in its first quarter, down from $268.2 million, or 83 cents a share, in the year-earlier period. The latest results included a charge of 8 cents a share, related to a terminated co-promotion agreement with Daiichi Sankyo. The New York pharmaceutical company said revenue...
The Earth Times Online Newspaper (Free subscription) | 07/22/2008
NEW YORK (Reuters) - Forest Laboratories Inc reported a 9 percent decline in quarterly profit on Tuesday on higher sales and administrative costs, but results were better than expected and the company forecast fiscal-year earnings ahead of analyst projections.
Reuters (Free subscription) | 07/22/2008
NEW YORK (Reuters) - Forest Laboratories Inc reported a 9 percent decline in quarterly profit on Tuesday on higher sales and administrative costs, but results were better than expected and the company forecast fiscal-year earnings ahead of analyst projections.
Alertnet (Free subscription) | 07/07/2008
... for gastrointestinal bleeding include a peptic ulcer or being elderly, he said.Some SSRIs include: Forest Laboratories Inc's
